Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RASLOW: Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy
NCT05236166Completed
- Sponsor
- University of Magna Graecia
- Start
- Apr 2017
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in epilepsy (2 arms), sponsored by University of Magna Graecia. Primary endpoint: Time to seizure relapse at 365 days. Started Apr 2017; status: completed.
02
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05236166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05236166.